[12] He also founded 2 biotechnology companies (Deep Piction and 1X1 Biotech) in 2022 with the aim of creating novel therapies to treat life-threatening illnesses such as cancer, Alzheimer's disease, and heart conditions.

The company's mission is to discover and develop new treatments for diseases with high unmet medical needs, such as cancer and rare genetic disorders.

1X1 Biotech's approach combines machine learning, network biology, and high-throughput screening to identify promising drug candidates and optimize their efficacy.

[27][28] One of 1X1 Biotech's primary aims is to improve the success rates of clinical trials by identifying biomarkers and patient subpopulations that are most likely to respond to a given treatment.

By using AI to analyze large amounts of data from clinical trials, the company hopes to improve the precision of drug development and bring new treatments to patients faster.